4.6 Article

Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease

Journal

AMERICAN JOURNAL OF PATHOLOGY
Volume 172, Issue 2, Pages 321-332

Publisher

ELSEVIER SCIENCE INC
DOI: 10.2353/ajpath.2008.070293

Keywords

-

Categories

Funding

  1. NIDDK NIH HHS [R01 DK062975, P30 DK034928, P30 DK-34928Y, DK062975, R01 DK054811-07, R01 DK062975-04, R01 DK054811, R01 DK058411, DK58411] Funding Source: Medline

Ask authors/readers for more resources

We evaluated the morphological and functional features of hepatic cyst epithelium in adult autosomal dominant polycystic kidney disease (ADPKD). in six ADPKD patients, we investigated the morphology of cyst epithelium apical surface by scanning electron microscopy and the expression of estrogen receptors (ERs), insulin-like growth factor 1(IGF1), IGF1 receptors (IGF1-R), growth hormone receptor, the proliferation marker proliferating cell nuclear antigen, and pAKT by immunohistochemistry and inummofluorescence. Proliferation of liver cyst-derived epithelial cells was evaluated by both MTS proliferation assay and [H-3] thymidine incorporation into DNA. The hepatic cyst epithelium displayed heterogeneous features, being normal in small cysts (< 1 cm), characterized by rare or shortened cilia in 1- to 3-cm cysts, and exhibiting the absence of both primary cilia and microvilli in large cysts (>3 cm). Cyst epithelium showed marked immunohistochemical expression of ER, growth hormone receptor, IGF1, IGF1-R, proliferating cell nuclear antigen, and pAKT. IGF1 was 10- fold more enriched in the hepatic cyst fluid than in serum. Serum-deprived liver cyst-derived epithelial cells proliferated when exposed to 17 beta-estradiol and lGF1 and when exposed to human cyst fluid. ER or IGF1-R antagonists inhibited the proliferative effect of serum readmission, cyst fluid, 17 beta-estradiol, and IGF1. Our findings; could explain the role of estrogens in accelerating the progression of ADPKD and may suggest a potential benefit of therapeutic strategies based on estrogen antagonism.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available